Evidence map›Paper›PMID 28510592›Full record

ArticlePLoS biology2017

Alteration of protein function by a silent polymorphism linked to tRNA abundance.

Sebastian Kirchner, Zhiwei Cai, Robert Rauscher, Nicolai Kastelic, Melanie Anding, Andreas Czech, Bertrand Kleizen, Lynda S Ostedgaard, Ineke Braakman, David N Sheppard and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The regulation, function and disease relevance of cytoplasmic tRNAs.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Codon-optimization in gene therapy: promises, prospects and challenges.Frontiers in bioengineering and biotechnology · 2024
    Review
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Sebastian KirchnerBiochemistry, Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany.
Zhiwei CaiSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Robert RauscherInstitute for Biochemistry and Molecular Biology, Department of Chemistry, University of Hamburg, Hamburg, Germany.
Nicolai KastelicBiochemistry, Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany.
Melanie AndingBiochemistry, Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany.
Andreas CzechInstitute for Biochemistry and Molecular Biology, Department of Chemistry, University of Hamburg, Hamburg, Germany.
Bertrand KleizenCellular Protein Chemistry, Department of Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
Lynda S OstedgaardDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa, United States of America.
Ineke BraakmanCellular Protein Chemistry, Department of Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
David N SheppardSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Zoya IgnatovaBiochemistry, Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany.
Universität Hamburg · DEUniversity of Potsdam · DEUniversity of Bristol · GBUtrecht University · NLUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synonymous single nucleotide polymorphisms (sSNPs) are considered neutral for protein function, as by definition they exchange only codons, not amino acids. We identified an sSNP that modifies the local translation speed of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to detrimental changes to protein stability and function. This sSNP introduces a codon pairing to a low-abundance tRNA that is particularly rare in human bronchial epithelia, but not in other human tissues, suggesting tissue-specific effects of this sSNP. Up-regulation of the tRNA cognate to the mutated codon counteracts the effects of the sSNP and rescues protein conformation and function. Our results highlight the wide-ranging impact of sSNPs, which invert the programmed local speed of mRNA translation and provide direct evidence for the central role of cellular tRNA levels in mediating the actions of sSNPs in a tissue-specific manner.

Indexed as

Silent MutationCystic Fibrosis Transmembrane Conductance RegulatorHEK293 CellsHeLa CellsHumansPolymorphism, Single NucleotideProtein StabilityRNA, TransferStructure-Activity RelationshipCystic Fibrosis Transmembrane Conductance RegulatorRNA, Transfer

Identifiers

PMID28510592
PMCPMC5433685
OpenAlexW2616018166

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.